Safety and efficacy of BG9924 in RA participants that have had an inadequate response to disease-modifying anti-rheumatic drug (DMARD) therapy.
experimental - one dose level
Placebo comparator
experimental - second dose level
experimental - third dose level
experimental - fourth dose level
experimental - fifth dose level
San Miguel de Tucumán, Argentina